How AI Can Revolutionize the Pharmaceutical Industry

  • Pallav Dave Regulatory Compliance Analyst, Louisville, KY, 40223, USA

Abstract

The pharmaceutical industry has seen a lot of transformation in the last five years because of technological innovations such as AI. AI-based technologies such as ML and DL are revolutionizing the sector and making processes such as drug discovery, research, dose optimization, therapeutic drug monitoring, drug repurposing, predictive analytics, and clinical trials much easier. Drug development is a complex, time consuming, and labor-intensive process. In some instances, drug development takes up to 10 years and a significant amount of investment. However, AI-based technologies are showing a lot of promise when it comes to simplifying the process and making it less-time consuming. The drug development involves a lot of data. AI-based technologies such as ML shows a lot of promise when it comes to analyzing and managing these large volumes of data making the process more manageable. AI has also simplified the process of identifying therapeutic targets. AI is also being used in drug design to help in making predictions of 3D structure of the target protein and predict drug-protein interactions. Other areas where AI is being used in drug discovery are de novo drug design, optimizing clinical trials, predictive modelling, and precision medicine. Despite the advantages that AI offers in pharma, it has its limitations. For instance, ethical considerations regarding patient data, privacy, and confidentiality remains a key issue. Risk of bias also raises ethical concerns that should be considered. Other limitations are limited skills that make it difficult to optimize AI, financial limitations that make it difficult to invest in AI, and data governance challenges.


Keywords: Artificial intelligence (AI), machine learning (ML), deep learning (DL), drug discovery, clinical trials

Keywords: Artificial intelligence (AI), machine learning (ML), deep learning (DL), drug discovery, clinical trials

Downloads

Download data is not yet available.

Author Biography

Pallav Dave, Regulatory Compliance Analyst, Louisville, KY, 40223, USA

Regulatory Compliance Analyst, Louisville, KY, 40223, USA

References

1. Bender A, Cortés-Ciriano I. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet. Drug Discovery Today. 2021;26(2):511-24. https://doi.org/10.1016/j.drudis.2020.12.009 PMid:33346134
2. Shahin MH, Barth A, Podichetty JT, et al. Artificial intelligence: from buzzword to useful tool in clinical pharmacology. Clinical Pharmacology & Therapeutics. 2024;115(4):698-709. https://doi.org/10.1002/cpt.3083 PMid:37881133
3. Dara S, Dhamercherla S, Jadav SS, Babu CM, Ahsan MJ. Machine learning in drug discovery: a review. Artificial Intelligence Review. 2022;55(3):1947-99. https://doi.org/10.1007/s10462-021-10058-4 PMid:34393317 PMCid:PMC8356896
4. Vora LK, Gholap AD, Jetha K, Thakur RR, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916. https://doi.org/10.3390/pharmaceutics15071916 PMid:37514102 PMCid:PMC10385763
5. Alowais SA, Alghamdi SS, Alsuhebany N, et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Medical Education. 2023;23(1):689. https://doi.org/10.1186/s12909-023-04698-z PMid:37740191 PMCid:PMC10517477
6. Zhavoronkov A, Vanhaelen Q, Oprea TI. Will artificial intelligence for drug discovery impact clinical pharmacology?. Clinical Pharmacology & Therapeutics. 2020;107(4):780-5. https://doi.org/10.1002/cpt.1795 PMid:31957003 PMCid:PMC7158211
7. Carracedo-Reboredo P, Liñares-Blanco J, Rodríguez-Fernández N, et al. A review on machine learning approaches and trends in drug discovery. Computational And Structural Biotechnology Journal. 2021;19:4538-58. https://doi.org/10.1016/j.csbj.2021.08.011 PMid:34471498 PMCid:PMC8387781
8. Pun FW, Ozerov IV, Zhavoronkov A. AI-powered therapeutic target discovery. Trends in Pharmacological Sciences. 2023. doi:10.1016/j.tips.2023.06.010 https://doi.org/10.1016/j.tips.2023.06.010 PMid:37479540
9. Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. British Journal of Pharmacology. 2011;162(6):1239-49. https://doi.org/10.1111/j.1476-5381.2010.01127.x PMid:21091654 PMCid:PMC3058157
10. Paul D, Sanap G, Shenoy S, et al. Artificial Intelligence in drug discovery and development. Drug Discovery Today. 2021; 26(1),80-93. https://doi.org/10.1016/j.drudis.2020.10.010 PMid:33099022 PMCid:PMC7577280
11. Vatansever S, Schlessinger A, Wacker D, et al. Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions. Medicinal Research Reviews. 2021;41(3):1427-73. https://doi.org/10.1002/med.21764 PMid:33295676 PMCid:PMC8043990
12. Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-9. https://doi.org/10.1038/s41586-021-03819-2 PMid:34265844 PMCid:PMC8371605
13. Mouchlis VD, Afantitis A, Serra A, et al. Advances in de novo drug design: from conventional to machine learning methods. International Journal of Molecular Sciences. 2021;22(4):1676. https://doi.org/10.3390/ijms22041676 PMid:33562347 PMCid:PMC7915729
14. Chhina A, Trehan K, Saini M, et al. Revolutionizing pharmaceutical industry: the radical impact of artificial intelligence and machine learning. Current Pharmaceutical Design. 2023;29(21):1645-58. https://doi.org/10.2174/1381612829666230807161421 PMid:37550904
15. Husnain A, Rasool S, Saeed A, Hussain HK. Revolutionizing pharmaceutical research: harnessing machine learning for a paradigm shift in drug discovery. International Journal of Multidisciplinary Sciences and Arts. 2023;2(2):149-57. https://doi.org/10.47709/ijmdsa.v2i2.2897
16. Harrer S, Shah P, Antony B, Hu J. Artificial intelligence for clinical trial design. Trends in Pharmacological Sciences. 2019;40(8):577-91. https://doi.org/10.1016/j.tips.2019.05.005 PMid:31326235
17. Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nature Biotechnology. 2014;32(1):40-51. https://doi.org/10.1038/nbt.2786 PMid:24406927
18. Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it?. Acta Pharmaceutica Sinica B. 2022;12(7):3049-62. https://doi.org/10.1016/j.apsb.2022.02.002 PMid:35865092 PMCid:PMC9293739
19. The Challenges of Chronic Wound Care and Management. Asian Journal of Dental and Health Sciences, 2024;4(1):45-50. https://doi.org/10.22270/ajdhs.v4i1.70
20. Schuhmacher A, Gatto A, Kuss M, Gassmann O, Hinder M. Big Techs and startups in pharmaceutical R&D-A 2020 perspective on artificial intelligence. Drug Discovery Today. 2021;26(10):2226-31. https://doi.org/10.1016/j.drudis.2021.04.028 PMid:33965571
21. Mak KK, Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today. 2019;24(3):773-80. https://doi.org/10.1016/j.drudis.2018.11.014 PMid:30472429
22. Segura-Bedmar I, Raez P. Cohort selection for clinical trials using deep learning models. Journal of the American Medical Informatics Association. 2019;26(11):1181-8. https://doi.org/10.1093/jamia/ocz139 PMid:31532478 PMCid:PMC6798560
23. Qureshi R, Irfan M, Gondal TM, Khan S, Wu J, Hadi MU, Heymach J, Le X, Yan H, Alam T. AI in drug discovery and its clinical relevance. Heliyon. 2023; 9(7): e17575. https://doi.org/10.1016/j.heliyon.2023.e17575 PMid:37396052 PMCid:PMC10302550
24. Chun M. How artificial intelligence is revolutionizing drug discovery. Harvard Law. 2023. Available from: https://blog.petrieflom.law.harvard.edu/2023/03/20/how-artificial-intelligence-is-revolutionizing-drug-discovery/
25. Exscientia. Exscientia Announces Sixth Molecule Created Through Generative AI Platform to Enter Clinical Stage. Available from: https://investors.exscientia.ai/press-releases/press-release-details/2023/Exscientia-Announces-Sixth-Molecule-Created-Through-Generative-AI-Platform-to-Enter-Clinical-Stage/default.aspx
26. Chen H, Engkvist O, Wang Y, Olivecrona M, Blaschke T. The rise of deep learning in drug discovery. Drug Discovery Today. 2018;23(6):1241-50. https://doi.org/10.1016/j.drudis.2018.01.039 PMid:29366762
27. Mitchell JB. Artificial intelligence in pharmaceutical research and development. Future Medicinal Chemistry. 2018;10(13):1529-31. https://doi.org/10.4155/fmc-2018-0158 PMid:29966438
28. Singh S, Kumar R, Payra S, Singh SK. Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery. Cureus. 2023;15(8). https://doi.org/10.7759/cureus.44359
29. Askr H, Elgeldawi E, Aboul Ella H, Elshaier YA, Gomaa MM, Hassanien AE. Deep learning in drug discovery: an integrative review and future challenges. Artificial Intelligence Review. 2023;56(7):5975-6037. https://doi.org/10.1007/s10462-022-10306-1 PMid:36415536 PMCid:PMC9669545
30. Ekins S. The next era: deep learning in pharmaceutical research. Pharmaceutical research. 2016;33(11):2594-603. https://doi.org/10.1007/s11095-016-2029-7 PMid:27599991 PMCid:PMC5042864
31. Yadav S, Singh A, Singhal R, Yadav JP. Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry. Intelligent Pharmacy. 2024; 2(3):367-380. https://doi.org/10.1016/j.ipha.2024.02.009
32. Blasiak A, Khong J, Kee T. CURATE. AI: optimizing personalized medicine with artificial intelligence. SLAS Technology: Translating Life Sciences Innovation. 2020;25(2):95-105. https://doi.org/10.1177/2472630319890316 PMid:31771394
33. Bohlmann A, Mostafa J, Kumar M. Machine learning and medication adherence: scoping review. JMIRx Med. 2021;2(4):e26993. https://doi.org/10.2196/26993 PMid:37725549 PMCid:PMC10414315
34. Khan O, Parvez M, Kumari P, Parvez S, Ahmad S. The future of pharmacy: how AI is revolutionizing the industry. Intelligent Pharmacy. 2023;1(1):32-40. https://doi.org/10.1016/j.ipha.2023.04.008
35. Chalasani SH, Syed J, Ramesh M, Patil V, Kumar TP. Artificial intelligence in the field of pharmacy practice: A literature review. Exploratory Research in Clinical and Social Pharmacy. 2023;12:100346. https://doi.org/10.1016/j.rcsop.2023.100346 PMid:37885437 PMCid:PMC10598710
36. Selvaraj C, Chandra I, Singh SK. Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. Molecular Diversity. 2021:1-21. https://doi.org/10.1007/s11030-021-10326-z PMid:34686947 PMCid:PMC8536481
37. Henstock PV. Artificial intelligence for pharma: time for internal investment. Trends in Pharmacological Sciences. 2019;40(8):543-6. https://doi.org/10.1016/j.tips.2019.05.003 PMid:31204059
38. Lee D, Yoon SN. Application of artificial intelligence-based technologies in the healthcare industry: Opportunities and challenges. International Journal of Environmental Research and Public Health. 2021;18(1):271. https://doi.org/10.3390/ijerph18010271 PMid:33401373 PMCid:PMC7795119
39. Blanco-Gonzalez A, Cabezon A, Seco-Gonzalez A, Conde-Torres D, Antelo-Riveiro P, Pineiro A, Garcia-Fandino R. The role of ai in drug discovery: challenges, opportunities, and strategies. Pharmaceuticals. 2023;16(6):891. https://doi.org/10.3390/ph16060891 PMid:37375838 PMCid:PMC10302890
40. Kumar M, Nguyen TN, Kaur J, Singh TG, Soni D, Singh R, Kumar P. Opportunities and challenges in application of artificial intelligence in pharmacology. Pharmacological Reports. 2023;75(1):3-18. https://doi.org/10.4155/fmc-2021-0243 PMid:34939433
41. Lavecchia A. Deep learning in drug discovery: opportunities, challenges and future prospects. Drug Discovery Today. 2019;24(10):2017-32. https://doi.org/10.1016/j.drudis.2019.07.006 PMid:31377227
Crossmark
Statistics
95 Views | 46 Downloads
How to Cite
1.
Dave P. How AI Can Revolutionize the Pharmaceutical Industry. JDDT [Internet]. 15Jun.2024 [cited 17Jul.2024];14(6):179-83. Available from: https://jddtonline.info/index.php/jddt/article/view/6657